Manufacturing of CD34 + HPC-enriched, high-purity mononuclear cell products from umbilical cord blood
Crossref DOI link: https://doi.org/10.1007/s10561-023-10070-8
Published Online: 2023-02-03
Published Print: 2023-12
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Wynn, Liam http://orcid.org/0000-0002-0821-659X
Wilson, Marnie Grace
Leonforte, Christopher
Text and Data Mining valid from 2023-02-03
Version of Record valid from 2023-02-03
Article History
Received: 17 February 2022
Accepted: 10 January 2023
First Online: 3 February 2023
Declarations
:
: The authors have no commercial, proprietary or financial interest in the products or companies described in this article.